← Eichor
Condition: Viral Sepsis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Viral Sepsis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT07347769Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Phase N/A · 3 location(s) · Amsterdam University Medical Centers (UMC), Location Academi · NCT06178822Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Phase N/A · 1 location(s) · Osijek University Hospital · NCT05181696HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT04513626A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients
Phase 3 · 13 location(s) · The University of Queensland · NCT05325008Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
Phase N/A · 1 location(s) · Sichuan Provincial People's Hospital · NCT06491966Emergency PWAS in Respiratory Infectious Disease
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05336851Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Cent
NA · 1 location(s) · National Taiwan University Hospital · NCT07294547PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY
NA · 2 location(s) · Centre for Infectious Disease Research in Zambia · NCT07021092Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
Phase N/A · 1 location(s) · University Hospital Hradec Kralove · NCT04887623Expansion of Virus-Specific Lymphocytes for Cell Therapy
Phase 1 · 1 location(s) · Hospital Israelita Albert Einstein · NCT06011486CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Unde
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06059391A Controlled Human Infection Model of Dengue
NA · 1 location(s) · Tan Tock Seng Hospital · NCT07412483PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
Phase 1 · 1 location(s) · University of California, San Francisco · NCT03729752Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NA · 1 location(s) · Indiana University · NCT06999928Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise
Phase N/A · 1 location(s) · Salem Anaesthesia Pain Clinic · NCT05862454Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06657781Immune Modulation by Exosomes in COVID-19
Phase N/A · 1 location(s) · University of Ulm · NCT05191381Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
Phase 4 · 8 location(s) · Fundacion para la Formacion e Investigacion Sanitarias de la · NCT06646562Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
Phase N/A · 1 location(s) · Guangzhou 8th People's Hospital · NCT06145828Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression
NA · 1 location(s) · University of Texas, El Paso · NCT05377463The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY
NA · 2 location(s) · University of Toronto · NCT06823596Immune Responses to Dengue and Sepsis
Phase N/A · 3 location(s) · Institut Pasteur du Cambodge · NCT07040202Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies
Phase N/A · 1 location(s) · Guangzhou 8th People's Hospital · NCT06145841Adaptability of an Undetectable = Untransmissible Model for HBV
Phase N/A · 1 location(s) · NYU Langone Health · NCT07449091Neutralizing Power of Serum Antibodies - 2
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07085611Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Phase 2/Phase 3 · 2 location(s) · Columbia University · NCT07079735A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Phase 2 · 1 location(s) · The Methodist Hospital Research Institute · NCT07383649
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.